Day Two - Western European Summer Time (WEST)
The healthcare industry has always evolved, but the scale and pace of change have accelerated in recent years—with major shifts across policy, technology and the broader healthcare landscape. What do these changes mean for biopharma companies and how they bring products to market? How do they affect revenue potential, clinical program design and other critical launch preparations?
Join this session to:
- Hear the latest research and data on what drives launch success today
- Gain practical insights on how to prepare for future market dynamics
- Learn from an expert panel discussion exploring real-world examples and implications for launch strategy
- Mark Rayward-Smith - Principal, ZS
The healthcare industry has always evolved, but the scale and pace of change have accelerated in recent years—with major shifts across policy, technology and the broader healthcare landscape. What do these changes mean for biopharma companies and how they bring products to market? How do they affect revenue potential, clinical program design and other critical launch preparations?
Join this session to:
- Hear the latest research and data on what drives launch success today
- Gain practical insights on how to prepare for future market dynamics
- Learn from an expert panel discussion exploring real-world examples and implications for launch strategy
- Mark Rayward-Smith - Principal, ZS
- Matthias Hess - SVP Head of Europe, SpringWorks Therapeutics
- Rasmus Just - Global Head, Business Development, M&A, Licensing, Search & Evaluation, ALK
- Elin Trampe - CEO, Dicot Pharma
- Jonas Båtelson - CEO, Curacell
- Khatereh Ahmadi - Venture Partner, XGEN Venture
- Sonal Patel - VP, Oncology Scientific Innovation, Johnson & Johnson Innovation
- Alan Rigby - CEO, Epitopea
- Paul-Peter Tak - President & CEO, Candel Therapeutics
- Ana Slipicevic - CEO, One-Carbon Therapeutics
- Carlos Buesa - CEO, Oryzon Genomics
- Francis Pang - SVP, Global Market Access & International Geographic Expansion, Orchard Therapeutics
- Ulf Staginnus - VP International Market Access & Pricing, Blueprint Medicines
- René Schüler - VP, Head of Market Access Europe, SpringWorks Therapeutics

